High levels of anxiety during the COVID-19 pandemic as a risk factor of clinical worsening in patients with severe asthma.
作者信息
Lacwik Piotr, Szydłowska Dorota, Kupczyk Maciej, Pałczyński Cezary, Kuna Piotr
机构信息
Collegium Medicum, Jan Kochanowski University, Kielce, Poland; Clinical Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
Clinical Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
出版信息
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1381-1383. doi: 10.1016/j.jaip.2020.12.060. Epub 2021 Jan 10.
Abstract
摘要
相似文献
1
High levels of anxiety during the COVID-19 pandemic as a risk factor of clinical worsening in patients with severe asthma.新冠疫情期间的高度焦虑作为重度哮喘患者临床病情恶化的一个风险因素。
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1381-1383. doi: 10.1016/j.jaip.2020.12.060. Epub 2021 Jan 10.
2
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.COVID-19 风险和结局在接受生物制剂或全身皮质类固醇治疗的成年哮喘患者中的：全国真实世界证据。
J Allergy Clin Immunol. 2021 Aug;148(2):361-367.e13. doi: 10.1016/j.jaci.2021.06.006. Epub 2021 Jun 15.
3
Severe asthma and COVID-19: lessons from the first wave.严重哮喘与 COVID-19：来自第一波疫情的教训。
J Asthma. 2022 Feb;59(2):239-242. doi: 10.1080/02770903.2020.1861622. Epub 2020 Dec 16.
4
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic.生物制剂可减轻严重哮喘患者的心理困扰、焦虑和抑郁，尽管有新冠疫情。
Respir Med. 2022 Aug-Sep;200:106916. doi: 10.1016/j.rmed.2022.106916. Epub 2022 Jun 27.
5
[COVID-19 and asthma].[新型冠状病毒肺炎与哮喘]
Rev Med Liege. 2020;75(S1):130-132.
6
Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak.545例在新型冠状病毒肺炎疫情期间接受生物治疗的重度哮喘患者的临床特征
J Allergy Clin Immunol Pract. 2021 Jan;9(1):487-489.e1. doi: 10.1016/j.jaip.2020.09.050. Epub 2020 Oct 9.
7
Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic.新冠疫情全国封锁期间接受生物制剂治疗的银屑病患者的依从性、安全担忧及焦虑：捷克共和国的一项多中心研究
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e682-e684. doi: 10.1111/jdv.16771. Epub 2020 Jul 9.
8
COVID-19 in patients with severe asthma using biological agents.COVID-19 与使用生物制剂的重症哮喘患者。
Tuberk Toraks. 2021 Sep;69(3):433-436. doi: 10.5578/tt.20219721.
9
Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019.哮喘、严重急性呼吸综合征冠状病毒 2 型和 2019 年冠状病毒病。
Curr Opin Allergy Clin Immunol. 2021 Apr 1;21(2):182-187. doi: 10.1097/ACI.0000000000000720.
10
Pediatric asthma control during the COVID-19 pandemic.儿童哮喘在 COVID-19 大流行期间的控制。
Immun Inflamm Dis. 2021 Jun;9(2):561-568. doi: 10.1002/iid3.418. Epub 2021 Mar 3.
引用本文的文献
1
The Interaction Between Asthma, Emotions, and Expectations in the Time of COVID-19.COVID-19 时期哮喘、情绪与期望之间的相互作用
J Asthma Allergy. 2023 Oct 20;16:1157-1175. doi: 10.2147/JAA.S418840. eCollection 2023.
2
Anxiety in adults with asthma during the coronavirus disease 2019 pandemic: a Canadian perspective.2019年冠状病毒病大流行期间成年哮喘患者的焦虑情绪：加拿大视角
Allergy Asthma Clin Immunol. 2023 Aug 23;19(1):73. doi: 10.1186/s13223-023-00833-z.
3
Adolescent Views on Asthma Severity and Management During the COVID-19 Pandemic.青少年对 COVID-19 大流行期间哮喘严重程度和管理的看法。
Pediatr Allergy Immunol Pulmonol. 2023 Mar;36(1):23-28. doi: 10.1089/ped.2022.0143. Epub 2023 Feb 15.
4
Management of patients with allergic diseases in the era of COVID-19.2019冠状病毒病时代过敏性疾病患者的管理
Clin Exp Pediatr. 2022 Nov;65(11):529-535. doi: 10.3345/cep.2022.00759. Epub 2022 Sep 23.
5
Clinical Characteristics and Disease Burden of Severe Asthma According to Oral Corticosteroid Dependence: Real-World Assessment From the Korean Severe Asthma Registry (KoSAR).根据口服糖皮质激素依赖情况分析重度哮喘的临床特征和疾病负担：来自韩国重度哮喘登记处（KoSAR）的真实世界评估
Allergy Asthma Immunol Res. 2022 Jul;14(4):412-423. doi: 10.4168/aair.2022.14.4.412.
6
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic.生物制剂可减轻严重哮喘患者的心理困扰、焦虑和抑郁，尽管有新冠疫情。
Respir Med. 2022 Aug-Sep;200:106916. doi: 10.1016/j.rmed.2022.106916. Epub 2022 Jun 27.
7
Psychological impacts of coronavirus disease 2019 on people with asthma, allergic rhinitis, and food allergy.新型冠状病毒病 2019 对哮喘、过敏性鼻炎和食物过敏患者的心理影响。
Ann Allergy Asthma Immunol. 2022 Jul;129(1):52-61. doi: 10.1016/j.anai.2021.12.013. Epub 2021 Dec 29.
8
The Role of Comorbidities in Difficult-to-Control Asthma in Adults and Children.合并症在成人和儿童中难治性哮喘的作用。
J Allergy Clin Immunol Pract. 2022 Feb;10(2):397-408. doi: 10.1016/j.jaip.2021.11.016. Epub 2021 Dec 1.
Zotero 插件